IL6 and melanoma: Similar observations have recently been reported by other investigators, as well, for example lower IL-6 and IL-8 levels at baseline as well as after 1 cycle of treatment were strongly linked to longer survival under immunotherapy in patients with lung cancer and melanoma from a prospective multicenter study in Italy (45).